Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Weight management

Recent news which mentions Weight management

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Tags Enterprise Technology Pharmaceuticals
From CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
Tags Weight management Pharmaceuticals Make It
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Wall Street Eli Lilly and Co Diabetes
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health & Science Health Insurance Small Business Playbook
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Business Weight management Pharmaceuticals
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Herbalife Ltd Novo Nordisk A/S WW International Inc
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Animal health Zoetis Inc Weight management
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Health insurance Obesity CNBC Global CFO Council
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Roche Holding AG Health care industry Eli Lilly and Co
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Novo Nordisk A/S Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Pfizer Inc Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Breaking news Business Weight management
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Apple Inc Technology Mobile
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Diabetes Health care industry Eli Lilly and Co
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Brand acquisitions CEO Pharmaceuticals
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Health care industry Eli Lilly and Co Diabetes
From CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
Tags Biotechnology Social issues Companies
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Kroger Co Health care industry Eli Lilly and Co
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Health care industry Clinical trials Heart attack
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Deals & IPOs Obesity Breaking news
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags CVS Health Corp Weight loss surgery Medicare health plans
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Eli Lilly and Co Health care industry Clinical trials
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Europe News
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Diabetes Eli Lilly and Co Health care industry
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Regulations
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Social issues Biotechnology US: News
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Biotechnology Companies US: News
From CNBC.com News
TikTokers say berberine is 'nature's Ozempic': Here's what doctors want you to know about the buzzy supplement
Tags Medication Health Tips and Wellness Advice Make It / Life
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.